Know Cancer

or
forgot password

Radiofrequency Ablation of Uterine Fibroids


Phase 0
18 Years
N/A
Not Enrolling
Female
Uterine Fibroids

Thank you

Trial Information

Radiofrequency Ablation of Uterine Fibroids


Inclusion Criteria:



- 18 years of age or older

- Diagnosed with uterine leiomyomas (fibroids)

- Patient will undergo surgical hysterectomy

- Patient is willing to sign informed consent form

Exclusion Criteria:

- Patients with acute infection

- Patients with bleeding disorders

- Patients who are not candidates for surgery or general anesthesia

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Following the hysterectomy, the study pathologist will perform a histological examination of the treated fibroid specimen to determine the size and volume of the ablation that was created with radiofrequency electrocautery.

Outcome Time Frame:

3 years

Safety Issue:

Yes

Principal Investigator

John P. McGahan, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of California, Davis

Authority:

United States: Institutional Review Board

Study ID:

200412085

NCT ID:

NCT00584207

Start Date:

March 2004

Completion Date:

July 2008

Related Keywords:

  • Uterine Fibroids
  • uterine fibroids
  • Leiomyoma
  • Myofibroma

Name

Location

UC Davis Medical Center Sacramento, California  95817